I don't follow the other players except for here. Are their scrips leveling off as you say? And what about ex-US, or has that market barely started with the newest treatment regimens?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.